PARP expression in germ cell tumours

High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer

(2012) Frederick Klauschen et al.   HISTOPATHOLOGY

The clinical development of inhibitors of poly(ADP-ribose) polymerase

(2011) H. Calvert et al.   ANNALS OF ONCOLOGY

PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy

(2011) Pawel Domagala et al.   BREAST CANCER RESEARCH AND TREATMENT

Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas

(2010) Salvatore Ulisse et al.   BMC CANCER

Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines

(2010) Hideki Ogino et al.   CANCER GENETICS AND CYTOGENETICS

Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors

(2009) Ana M. Mendes-Pereira et al.   EMBO Molecular Medicine

PARP1 Poly(ADP-ribosyl)ates Sox2 to Control Sox2 Protein Levels andFGF4Expression during Embryonic Stem Cell Differentiation

(2009) Furong Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

RETRACTED ARTICLE: Poly(Adenosine Diphosphate-Ribose) Polymerase-1 Expression in Cutaneous Malignant Melanomas as a New Molecular Marker of Aggressive Tumor

(2009) Béla Csete et al.   PATHOLOGY & ONCOLOGY RESEARCH

Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas

(2008) Federica Barbagallo et al.   JOURNAL OF PATHOLOGY